Physician profile
Kai E Engstad
NPI 1174793830
$6,892.27
in general payments reported to CMS, 2019-2025
23 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,241 · 2020: $1,190 · 2021: $533 · 2022: $500 · 2023: $1,170 · 2024: $113 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $816 · Food and Beverage: $612.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $815.64 |
| Food and Beverage | $612.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,537.25 | 2019-2022 | |
| Edwards Lifesciences Corporation | $1,445.96 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Inspiris Resilia Aortic Valve, Konect Resilia |
| Artivion, INC. | $383.35 | 2019-2021 | |
| Ethicon US, LLC | $261.91 | 2019-2024 | Echelon Flex, Vistaseal, Dermabond Prineo |
| Medtronic, INC. | $195.34 | 2021-2025 | Avalus |
| Abiomed | $166.93 | 2019-2022 | |
| Getinge USA Sales, LLC | $139.81 | 2019-2025 | Vasoview Hemopro 2, Vasoview Hemopro 2 |
| Atricure, INC. | $139.74 | 2019-2024 | |
| Medtronic Vascular, INC. | $113.33 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $97.06 | 2022-2023 | Sternalock Blu System |
| Davol INC. | $61.31 | 2020 | |
| Convatec INC. | $50.75 | 2019-2021 | |
| Clearflow INC. | $43.00 | 2019 | |
| Becton, Dickinson and Company | $32.02 | 2019 | |
| Kci USA, INC. | $30.35 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $29.67 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $27.85 | 2019 | |
| Depuy Synthes Sales INC. | $26.63 | 2023 | Matrixrib |
| Portola Pharmaceuticals, LLC | $25.19 | 2019 | |
| Lemaitre Vascular, INC. | $24.75 | 2021 | |
| Bard Access Systems, INC. | $23.54 | 2019 | |
| Baxter Healthcare | $20.13 | 2019 | |
| Covidien Lp | $16.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kai Engstad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.